DARE

Conviction 38HealthcareScan · Mon, Jul 20, 2026

DARE$1.34-31.89%

ResistanceSupportVol 14

Vol MA14 155.42K

Apr 20May 6May 26Jun 11Jul 1Jul 20

WSB mentions · 24h changelatest +100.00%· 2 mentions

Apr 20May 6May 26Jun 11Jul 1Jul 20

Dare Bioscience, Inc.PHARMACEUTICAL PREPARATIONSwww.darebioscience.com ↗

Price1.34

Change-31.89%

Gap-4.08%

Rel volume5.58×

Avg volume154.36K

Avg $ vol291.22K

SMA 202.02

SMA 502.17

SMA 2001.98

Price vs 50-38.39%

Price vs 200-32.67%

MA stackmixed

50/200 cross—

Supertrenddown · 2.10

RSI (14)22

MACD hist-0.05

MACD crossbear · 2d

Stoch %K / %D0 / 10

ADX (14)14

+DI / −DI12 / 39

RSI divergence—

MACD divergence—

ATR %+12.13%

ADR %7.16%

52w high3.27

52w low1.30

From 52w high-59.17%

Above 52w low+2.69%

New 52w highNo

SqueezeFired

Bollinger width32.41%

%B-0.55

Donchian pos0.00%

Donchian high2.21

Donchian low1.34

AVWAP (52w high)2.52

vs AVWAP high-46.96%

AVWAP (52w low)2.60

vs AVWAP low-48.70%

OBV trendDown

Chaikin MF (20)-0.36

Today vs 20d5.58×

Avg vol (14d)155.42K

Avg vol (20d)154.36K

Avg $ vol (20d)291.22K

Market cap20M

RS 3m (vs SPY)-33.87%

RS 6m (vs SPY)-11.12%

RS line new highNo

Trend template2/8

Technical rank7.7

1 week-36.12%

1 month-35.82%

3 months-54.75%

6 months-31.54%

1 year-46.60%

YTD-31.54%

P/E-1.49

P/B27.23

P/S19.41

P/FCF-1.95

EPS-1.20

Div yield—

ROE—

ROA-48.15%

Debt/Eq0.01

Current1.03

EV/EBITDA-0.12

Gross margin—

Net margin—

Rev growth—

EPS growth-230.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.49M

Revenue152.46K

Net income-3M

Gross profit—

Free cash flow-10.27M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out14.98M

Employees24

ListedThu, Apr 10, 2014

Free float13.52M

Float %94.6%

Short interest691.07K

Days to cover4.0d

Short volume43.0%

Squeeze score47 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank7.7 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.36

Support1.85

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DARE

All disclosures →

No recent disclosed trades by Congress in DARE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DARE

No recent insider (Form 4) filings in DARE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DARE · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.